Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

5.3K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.3K
Tumor Progression02:07

Tumor Progression

7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Dual-input deep learning bone age assessment in late adolescence using hand and knee radiographs.

Skeletal radiology·2026
Same author

Quantitative mechanism separation of single-event transients in nanosheet transistors via TCAD simulation.

Nanotechnology·2026
Same author

Development of Curcumin/ADP-Loaded Gelatin Methacrylate Hydrogel for Enhanced Wound Healing with Hemostatic, Anti-Inflammatory, and Antibacterial Properties.

Gels (Basel, Switzerland)·2026
Same author

Exploring shared biomarkers and their mechanisms in thyroid cancer and systemic lupus erythematosus via bioinformatics analysis.

Discover oncology·2026
Same author

Second-level fast sintering enables high-brightness light source for visible light communication.

Nature communications·2026
Same author

Effects of Resistance Training on Breast Cancer-Related Lymphedema: A Meta-Analysis.

Archives of rehabilitation research and clinical translation·2026

相关实验视频

Updated: Jan 11, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.3K

赫克索金酶2促进瘤的发展和进展.

Guojuan Wang1, Yujuan Lai1,2, Xiudan Chen2

  • 1Affiliated Hospital of Jiangxi University of Chinese Medicine Nanchang 330006, Jiangxi, China.

American journal of cancer research
|November 17, 2025
PubMed
概括

赫索基纳酶2 (HK2) 通过驱动糖分解,对癌细胞生长至关重要. 准HK2为开发新的癌症疗法提供了一个有前途的战略.

关键词:
六甲基酶 2 基酶 2华堡效应是什么? 华堡效应灭症 (apoptosis) 是一种死亡的过程.药物耐药性 耐药性 药物耐药性它们的扩散和扩散.瘤代谢 瘤代谢

更多相关视频

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.5K
Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
11:11

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach

Published on: February 21, 2019

7.8K

相关实验视频

Last Updated: Jan 11, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.3K
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.5K
Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
11:11

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach

Published on: February 21, 2019

7.8K

科学领域:

  • 生物化学 生物化学
  • 在瘤学瘤学.
  • 代谢途径 代谢途径

背景情况:

  • 癌细胞表现出改变的新陈代谢,特别是增加了葡萄糖分解,以促进快速增殖.
  • 糖解提供能量和构建块,支持瘤的生存,入侵和转移.
  • 六酶 (HK) 酶是糖解的关键调节剂,HK2在癌症中尤为重要.

研究的目的:

  • 审查瘤发育和进展中赫索金酶2 (HK2) 的关键作用.
  • 讨论针对HK2进行癌症治疗的新兴治疗策略.
  • 为基于代谢的癌症疗法提供见解.

主要方法:

  • 关于HK2在癌症中的功能现有证据的文献综述.
  • 对证实各种癌症类型HK2上调的研究进行分析.
  • 探索针对HK的治疗方法2.2.

主要成果:

  • 在许多癌症中,HK2被显著上调,促进瘤的开始和进展.
  • HK2通过抑制亡,增强扩散和转移来促进癌症.
  • 准HK2为新型癌症治疗提供了潜在的途径.

结论:

  • HK2在癌症代谢重编程中发挥着中心作用,支持瘤生长和扩散.
  • 了解HK2与癌症之间的联系对于开发有效的基于代谢的疗法至关重要.
  • 准HK2对未来在瘤学中的临床应用具有前景.